
|Articles|October 15, 2014
- Gastrointestinal Cancers (Issue 3)
- Volume 3
- Issue 1
Immunotherapy and Viral Therapy for Pancreatic Cancer
Tanios Bekaii-Saab, MD, discusses the future of immunotherapy and viral therapy for the treatment of pancreatic cancer.
Advertisement
Articles in this issue
over 11 years ago
Unanswered Questions Regarding the Treatment of Pancreatic NETsover 11 years ago
Targeted Agents and Combinations Being Studied in Pancreatic NETsover 11 years ago
Sequencing Agents for the Treatment of Pancreatic NETsover 11 years ago
Research on Epidemiology of GIST Identifies Risk Factorsover 11 years ago
Antiangiogenic Strategies for mCRC Need Further Explorationover 11 years ago
Coping With Comorbidities in Hepatocellular Cancerover 11 years ago
Strategies in Surveillance: Hepatocellular CarcinomaAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Oncology Update January 2026: New Horizons in Precision Medicine
2
Gemogenovatucel-T Triples Overall Survival in High-Risk HRP Ovarian Cancer
3
Building Better ADCs for GI Cancers: Targets, Timing, and Toxicities
4
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
5



















